HomeLIXT • NASDAQ
add
Lixte Biotechnology Holdings Inc
Previous close
$3.07
Day range
$2.94 - $3.22
Year range
$0.64 - $6.26
Market cap
35.38M USD
Avg Volume
38.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.82M | 197.40% |
Net income | -2.54M | -311.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.11M | 391.54% |
Total assets | 12.73M | 1,011.62% |
Total liabilities | 1.77M | 456.76% |
Total equity | 10.96M | — |
Shares outstanding | 11.62M | — |
Price to book | 3.41 | — |
Return on assets | -50.21% | — |
Return on capital | -53.95% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.54M | -311.84% |
Cash from operations | -1.09M | -81.72% |
Cash from investing | -535.10K | — |
Cash from financing | 3.84M | — |
Net change in cash | 2.22M | 470.65% |
Free cash flow | 263.73K | 170.50% |
About
Founded
2005
Headquarters
Website
Employees
3
